Abliva develops medicines for the treatment of primary mitochondrial diseases.

Clinical Trials

Health Care

Biotechnology

Abliva AB

Ellen K. Donnelly

Eskil Elmér

Magnus Hansson

Catharina Jz. Johansson

Denise Goode

David Laskow-Pooley

David Bejker

Roger Franklin

Jan Törnell

The Leadership Team at Abliva AB is responsible for strategic decision-making, guiding the company's vision in developing therapies for primary mitochondrial diseases. Comprising key executives from various domains—including finance, discovery, and clinical development—they collaborate to ensure alignment of corporate objectives, optimize resource allocation, and drive innovation in research and development. Their leadership fosters a culture of excellence, ensuring that Abliva remains at the forefront of advancements in mitochondrial medicine.

Leadership Team

The Research and Development team at Abliva AB focuses on discovering, developing, and optimizing medicines for the treatment of primary mitochondrial diseases. Team members collaborate on preclinical and clinical trials, advance drug discovery, and ensure effective research management to bring new therapies to patients.

Research and Development

Abliva AB

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Offices

Abliva AB

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Offices

Related companies